Then, to corroborate the veracity of the expression peak of SFRP5 in SS samples and the downregulation in NASH ones, we have also analyzed the hepatic expression of IL-6 and TNF-α, well-known proinflammatory molecules, in SS and NASH groups. Here, SFRP5 is linked to metabolic dysfunction-associated steatohepatitis.